Lingyi Sun
About Lingyi Sun
Lingyi Sun is a Senior Scientist at Bristol Myers Squibb in Redwood City, California, specializing in organic synthesis, bioconjugation, and drug design.
Title and Current Company
Lingyi Sun holds the title of Senior Scientist and is currently working at Bristol Myers Squibb. Based in Redwood City, California, United States, Lingyi Sun is engaged in advanced research and development in the pharmaceutical industry. The role at Bristol Myers Squibb involves conducting and managing scientific experiments, project leadership, and collaboration with other researchers to drive innovation in drug discovery and development.
Professional Background
Lingyi Sun has accrued extensive experience in the field of scientific research through various roles in reputable institutions. From 2018 to 2021, they served as Research Staff at Oregon Health and Science University in Portland, Oregon. Prior to that, from 2014 to 2018, they were a Postdoctoral Associate at the University of Pittsburgh School of Medicine in the Greater Pittsburgh Area. Lingyi also has a background working as a PhD Candidate and Research Associate at the National University of Singapore from 2009 to 2014.
Educational Background
Lingyi Sun has an extensive educational background in medicinal chemistry and pharmacy. They earned a Doctor of Philosophy (Ph.D.) in Medicinal Chemistry from the National University of Singapore, studying there from 2009 to 2013. Prior to this, Lingyi completed a Bachelor's degree in Pharmacy from Shanghai Jiao Tong University, where they studied from 2004 to 2008. This educational foundation has provided them with a robust understanding of drug design, organic synthesis, and bioconjugation.
Areas of Expertise
Lingyi Sun specializes in several key areas within the field of scientific research, including organic synthesis, bioconjugation, and drug design. Their skills extend to proposing scientific hypotheses, executing comprehensive experiments, and interpreting data to meet research objectives. Lingyi's expertise is critical in developing new pharmaceutical compounds and advancing the understanding of drug interactions and effectiveness.
Continuous Professional Development
Beyond formal education and professional roles, Lingyi Sun is committed to continuous learning and professional development. They actively participate in seminars, workshops, and various learning opportunities to stay abreast of the latest advancements in the field. This dedication to ongoing education ensures they are always on the cutting edge of scientific research and development.